By Amira McKee
Shares of IQVIA Holdings retreated after the biotech company's adjusted earnings outlook for missed Wall Street's expectations.
The stock fell 9% to $185.16 in Thursday morning trading. The shares have declined 9.6% in the past year.
IQVIA expects adjusted earnings per share of $12.55 to $12.85, on revenue of $17.15 billion to $17.35 billion for the 2026 fiscal year.
Analysts polled by FactSet are looking for adjusted earnings of $12.93 per share, and revenue of $17.07 billion in 2026.
The guidance includes a step up in interest expense of approximately $80 million from annualization of financing activities completed in 2025 and expected refinancing to be completed in 2026.
The Durham, N.C., company logged fourth-quarter net income of $514 million, or $2.99 a share, compared with earnings of $437 million, or $2.42 a share, in the same period a year earlier.
Fourth-quarter revenue increased 10.3% to $4.36 billion, beating Wall Street's forecast of $4.24 billion.
Write to Amira McKee at amira.mckee@wsj.com
(END) Dow Jones Newswires
February 05, 2026 11:59 ET (16:59 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.